LapEmerge试验:急诊结肠切除术腹腔镜入路的研究方案——多中心、开放标签、随机对照试验
LapEmerge试验为多中心前瞻性随机对照试验,纳入需急诊结直肠切除的成人患者,比较腹腔镜与开腹入路。既往研究多为回顾性、单中心且样本量有限,腹腔镜尚存未报告的风险,需评估其安全性及与开腹相比的优缺点。试验注册号ClinicalTrials.gov NCT05005117,注册日期2021年8月12日。
要点
- LapEmerge为多中心前瞻性随机对照试验,比较急诊结直肠切除的腹腔镜与开腹入路。
- 既往报告均为回顾性、多为单中心、患者数量有限,腹腔镜可能存在未报告的风险。
- 试验注册号ClinicalTrials.gov NCT05005117,注册日期2021年8月12日。
核心结论
- 需评估腹腔镜急诊结直肠切除的安全性及其与开腹相比的优缺点。
研究设计与样本
- 多中心前瞻性随机对照试验,纳入需急诊结直肠切除的成人患者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 既往研究均为回顾性、多为单中心且患者数量有限。
- 腹腔镜可能涉及一些因技术使用不频繁而尚未报告不可预测的风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Due to faster recovery and lower morbidity rates, laparoscopy has become the gold standard in elective colorectal surgery for both the benign and malignant forms of the disease. A substantial proportion of colorectal operations are, however, carried out in emergency settings, and most of the emergency resections are still performed open. The aim of this study is to compare the laparoscopic versus open approach for emergency colorectal surgery. METHOD/DESIGN: This is a multicenter prospective randomized controlled trial including adult patients presenting with a condition requiring emergency colorectal resection. DISCUSSION: Previous studies cautiously recommend wider use of laparoscopy in emergency colorectal resections, but all earlier reports are retrospective, are mostly single-center studies, and have limited numbers of patients. Laparoscopy may involve some unpredictable risks that have not yet been reported because of the infrequent use of the techniqueded to assess the safety of laparoscopy as well as the advantages and disadvantages of open compared with laparoscopic emergency surgery. TRIAL REGISTRATION: Trial registration number: ClinicalTrials.gov NCT05005117 . Registered on August 12, 2021.
引用
- Grönroos-Korhonen MT, Kössi JAO. LapEmerge trial: study protocol for a laparoscopic approach for emergency colon resection-a multicenter, open label, randomized controlled trial. Trials. 2024. PMID: 38632602. doi:10.1186/s13063-024-08058-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。